Home INfusion & Specialty pharmacy
NHIA 2025 Conference
Recent Conference Insights
Our Healthcare Investment Banking team recently attended the NHIA ’25 Conference in Washington DC, where we had the chance to reconnect with numerous clients, investors, and industry leaders in the Home Infusion and Specialty Pharmacy space. With the Asembia Conference in Las Vegas coming up at the end of the month, we are seeing a noticeable increase in interest from Private Equity firms in this area of the healthcare ecosystem.
What’s Driving This M&A Activity?
Shift in Care Settings: There’s increasing pressure from payers to move patients from hospital-based infusion centers to home or Ambulatory Infusion Centers.
Pipeline of Specialty Infusion Drugs: A high number of specialty infusion pharmaceuticals are progressing through the FDA approval process, creating new opportunities in the market.
Private Equity Activity: After a slower couple of years, many investors are pressuring their Private Equity firms to put money to work and take action.
For more information or questions, please contact the Healthcare Services team:
Paul Kacik, Managing Director: pkacik@hexagoncapitalalliance.
Brad Erhart, Director: berhart@